HSTMHealthStream, Inc.

$35.13+32% 1Y
Latest close: a new 52-week highOct 23, 2026what changed →

Is the price fair?

Fair

Neither cheap nor expensive: growth expectations in line with delivery and in its normal P/E range.

2 neutral, 1 without data
What the price assumes~+2% a yearderived · Jun 30, 2026

Priced for ~2% a year FCF growth. Roughly in line with its three-year revenue growth of 5% a year.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 48.8 vs a 55.8 median over 41 quarters (−13% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What HSTM's price assumes

HealthStream, Inc. trades at 48.8× earnings against 46.9× for the median Health Information Services name, more expensive than its own group.

48.8

Trailing P/E · Health Information Services median 46.9 · 1.04× the median: the market pays up for this one

Price / sales
2.48

Price / sales · as of 2026-Q2

Free cash flow yield
6.8%

Free cash flow yield · Health Information Services median 4.5%

Growth the price implies
+1.6%

Growth the price implies · The price pays for +1.6% free cash flow growth a year for a decade; the business has delivered +14% a year over the last three.

Details›
Price / bookas of 2026-Q2
2.24
Healthcare median P/E503 names
27.9
Health Information Services median P/E24 names
46.9
Free cash flow, trailing twelve months
$70M
Market capitalisation29.2 million shares, counted Aug 3, 2026
$1.03B
3-year revenue growth
+5.4%
3-year free cash flow growth
+14%
What the market has paid for these earnings: 41 quarters of its own multiple × $0.72 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$29.77
Its own P/E history, median$40.17
Its own P/E history, upper quartile$69.95
52-week range$19.82 – $35.13
Today$35.13

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.